{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T16:26:20Z","timestamp":1776788780637,"version":"3.51.2"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.fertnstert.2021.02.047","type":"journal-article","created":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T07:50:18Z","timestamp":1617436218000},"page":"422-430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pretreatment antim\u00fcllerian hormone levels and outcomes of ovarian stimulation with gonadotropins\/intrauterine insemination cycles"],"prefix":"10.1016","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6195-6781","authenticated-orcid":false,"given":"Stylianos","family":"Vagios","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer Y.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin R.","family":"Sacha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Dimitriadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Christou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaitlyn E.","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles L.","family":"Bormann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Souter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2021.02.047_bib1","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.fertnstert.2015.03.019","article-title":"Diagnostic evaluation of the infertile female: a committee opinion","volume":"103","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.02.047_bib2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/rep.0.1240601","article-title":"Regulation of ovarian function: the role of anti-m\u00fcllerian hormone","volume":"124","author":"Durlinger","year":"2002","journal-title":"Reproduction"},{"key":"10.1016\/j.fertnstert.2021.02.047_bib3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10815-009-9332-8","article-title":"Serum anti-m\u00fcllerian hormone predicts ovarian response and cycle outcome in IVF patients","volume":"26","author":"Wu","year":"2009","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2021.02.047_bib4","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jama.2017.14588","article-title":"Association between biomarkers of ovarian reserve and infertility among older women of reproductive age","volume":"318","author":"Steiner","year":"2017","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.fertnstert.2021.02.047_bib5","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1472-6483(10)60480-4","article-title":"Anti-m\u00fcllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality?","volume":"16","author":"Lie Fong","year":"2008","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2021.02.047_bib6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/09513590.2018.1505850","article-title":"Women with extreme low AMH values could have in\u00a0vitro fertilization success","volume":"35","author":"Sefrioui","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2021.02.047_bib7","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00404-015-3901-0","article-title":"The influence of AMH on IVF success","volume":"293","author":"Gomez","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2021.02.047_bib8","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1471-0528.2004.00452.x","article-title":"Inhibin B and anti-mullerian hormone: markers of ovarian response in IVF\/ICSI patients?","volume":"111","author":"Muttukrishna","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.fertnstert.2021.02.047_bib9","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10815-016-0675-7","article-title":"IVF results in patients with very low serum AMH are significantly affected by chronological age","volume":"33","author":"Revelli","year":"2016","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2021.02.047_bib10","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.fertnstert.2013.12.039","article-title":"Value of antim\u00fcllerian hormone as a prognostic indicator of in\u00a0vitro fertilization outcome","volume":"101","author":"Reichman","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.02.047_bib11","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jogc.2017.01.029","article-title":"The value of anti-m\u00fcllerian hormone in predicting clinical pregnancy after intrauterine insemination","volume":"39","author":"Dondik","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.fertnstert.2021.02.047_bib12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jgyn.2011.08.005","article-title":"Intra-uterine insemination outcomes according to the serum AMH level on day 3. Article in French","volume":"41","author":"Lamazou","year":"2012","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.fertnstert.2021.02.047_bib13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12967-016-0924-7","article-title":"Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH","volume":"14","author":"Gleicher","year":"2016","journal-title":"J Transl Med"},{"key":"10.1016\/j.fertnstert.2021.02.047_bib14","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1210\/jc.2018-01320","article-title":"M\u00fcllerian-inhibiting substance\/anti-m\u00fcllerian hormone as a predictor of preterm birth in polycystic ovary syndrome","volume":"103","author":"Hsu","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.02.047_bib15","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.fertnstert.2018.01.039","article-title":"Antim\u00fcllerian hormone as a risk factor for miscarriage in naturally conceived pregnancies","volume":"109","author":"Lyttle Schumacher","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.02.047_bib16","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.fertnstert.2019.09.039","article-title":"High antim\u00fcllerian hormone levels are associated with preterm delivery in patients with polycystic ovary syndrome","volume":"113","author":"Hu","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.02.047_bib17","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.fertnstert.2010.11.062","article-title":"Women, weight, and fertility: the effect of body mass index on the outcome of superovulation\/intrauterine insemination cycles","volume":"95","author":"Souter","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.02.047_bib18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12958-015-0134-9","article-title":"Role of anti-m\u00fcllerian hormone in pathophysiology, diagnosis and treatment of polycystic ovary syndrome: a review","volume":"13","author":"Dumont","year":"2015","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2021.02.047_bib19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.02.047_bib20","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3109\/09513590.2015.1025381","article-title":"Can anti-mullerian hormone (AMH) predict the outcome of intrauterine insemination with controlled ovarian stimulation?","volume":"31","author":"Bakas","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2021.02.047_bib21","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.fertnstert.2009.12.059","article-title":"Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine insemination","volume":"94","author":"Li","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.02.047_bib22","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.fertnstert.2019.12.006","article-title":"Comparison of pregnancy outcomes following intrauterine insemination in young women with decreased versus normal ovarian reserve","volume":"113","author":"Tiegs","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.02.047_bib23","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1210\/jc.2016-1340","article-title":"Baseline AMH level associated with ovulation following ovulation induction in women with polycystic ovary syndrome","volume":"101","author":"Mumford","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.02.047_bib24","doi-asserted-by":"crossref","first-page":"59.e1","DOI":"10.1016\/j.ajog.2014.02.026","article-title":"Characterization of women with elevated antim\u00fcllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes","volume":"211","author":"Tal","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2021.02.047_bib25","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.rbmo.2018.08.012","article-title":"Towards international standardization of immunoassays for m\u00fcllerian inhibiting substance\/anti-m\u00fcllerian hormone","volume":"37","author":"Ferguson","year":"2018","journal-title":"Reprod Biomed Online"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028221001722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028221001722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:30:42Z","timestamp":1758011442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028221001722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0015028221001722"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2021.02.047","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pretreatment antim\u00fcllerian hormone levels and outcomes of ovarian stimulation with gonadotropins\/intrauterine insemination cycles","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2021.02.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92021 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}